TITLE

Influenza pandemic vaccines: how to ensure a low-cost, low-dose option

AUTHOR(S)
Stöhr, Klaus; Kieny, Marie-Paule; Wood, David
PUB. DATE
August 2006
SOURCE
Nature Reviews Microbiology;Aug2006, Vol. 4 Issue 8, p565
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
Global access to an effective influenza vaccine will be essential in the event of a pandemic. Here, the WHO's Klaus Stöhr, Marie-Paule Kieny and David Wood argue that assessing the clinical benefits of low-dose H5N1 vaccines in animal models is crucial to achieving this goal.
ACCESSION #
22005091

 

Related Articles

  • Potential role of flu vaccines, respiratory illness unknown.  // Infectious Disease News;Jul2013, Vol. 26 Issue 7, p17 

    The article discusses the results of a study led by Doctor Edward A. Belongia published in an online 2013 issue of the "Clinical Infectious Diseases Journal" which showed that influenza vaccines can lessen the risk of developing other respiratory viruses.

  • Erratum.  // MMWR: Morbidity & Mortality Weekly Report;9/12/2014, Vol. 63 Issue 36, p801 

    A correction to the article "Notes From the Field: Reports of Expired Live Attenuated Influenza Vaccine Being Administered: United States, 2007-2014" is presented.

  • Fighting Influenza. PARK, ALICE // Time;2/4/2013, Vol. 181 Issue 4, p15 

    The article presents information about influenza, or the flu, including the effects of giving children with egg allergies a flu vaccine, the percentage of U.S. workers that do not receive paid sick days, and a software application called "Help I Have the Flu" that tracks people who may be sick.

  • Survey of Human Antibody Responses to Influenza Virus Matrix Protein 2 by Use of a Sensitive Flow Cytometric Method. Epstein, Suzanne L.; García, Mayra // Journal of Infectious Diseases;Apr2014, Vol. 209 Issue 7, p975 

    An introduction is presented in which the editors discusses articles within the issue on topics including viral matrix proteins M1 and M2, human antibody responses to influenza virus, and influenza vaccines.

  • Influenza Vaccine: Flu Shot vs Nasal Mist. Kuritzky, Louis // Clinical Cardiology Alert;Dec2009 Clinical Briefs in Primary, p23 

    The article discusses a research on the efficacy of two major categories of trivalent influenza vaccine in preventing seasonal flu namely inactivated (shot) and live attenuated (nasal). It references a study by A. S. Monto and colleagues, published in "The New England Journal of Medicine." The...

  • Production of pilot lots of inactivated influenza vaccine in response to a pandemic threat: an interim biosafety risk assessment.  // Weekly Epidemiological Record;11/21/2003, Vol. 78 Issue 47, p405 

    Presents an interim biosafety risk assessment of the production of pilot lots of inactivated influenza vaccine in response to a pandemic threat. Necessity to develop safe vaccine strains; Analysis of the influenza virus genome; Details of reassortants and their production.

  • Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as pre-pandemic vaccines, March 2007.  // Weekly Epidemiological Record;5/11/2007, Vol. 82 Issue 19, p164 

    The article provides an update on the characterization of H5N1 viruses in birds and the development of pre-pandemic H5N1 candidate vaccine viruses by the World Health Organization's Global Influenza Program. The Program is conducting comparisons of the vaccine developed from clade 1 and clade 2...

  • Doubts over flu jabs for elderly.  // GP: General Practitioner;2/19/2010, p03 

    The article reports on a study by researcher Tom Jefferson and his team from The Cochrane Collaboration, which found that there is poor evidence for the effectiveness of influenza vaccines in elderly people. Researchers observed 75 comparative studies of the effects of influenza vaccines but...

  • Effects of an Ongoing Epidemic on the Annual Influenza Vaccination Rate and Vaccination Timing Among the Medicare Elderly: 2000-2005. Yoo, Byung-Kwang; Kasajima, Megumi; Fiscella, Kevin; Bennett, Nancy M.; Phelps, Charles E.; Szilagyi, Peter G. // American Journal of Public Health;Oct2009 Supplement, Vol. 99 Issue S2, pS383 

    Objectives. We assessed short-term responsiveness of influenza vaccine demand to variation in timing and severity of influenza epidemics since 2000. We tested the hypothesis that weekly influenza epidemic activity is associated with annual and daily influenza vaccine receipt. Methods. We...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics